Moderna, Inc. reports $389 million revenue for quarter ended March 31, 2026, up 260.2%
Moderna, Inc. reported revenue of $389 million for the quarter ended March 31, 2026, an increase of 260.2% from the same quarter a year earlier ($108 million).
For the same period it posted a net loss of $1.34 billion, or $-3.40 per diluted share (-2.52 a year earlier).
That is a net margin of -345.2%.
On Sanad's AAOIFI Standard 21 screen, Moderna, Inc. is currently not compliant: interest-bearing debt is 0.7% of market capitalisation (limit 30%), and impure income is 16.2% of revenue (limit 5%).
Is Moderna, Inc. halal?
See the full AAOIFI screening of Moderna, Inc.
See the full AAOIFI screening of Moderna, Inc.
Source: 10-Q filed with the U.S. Securities and Exchange Commission on May 1, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.